The hypoxia-inducible epigenetic regulators Jmjd1a and G9a provide a mechanistic link between angiogenesis and tumor growth

Molecular and Cellular Biology

Volumn 34, Issue 19, 2014, Pages 3702-3720

  Ueda, Jun ^a,d   Ho, Jolene Caifeng ^a   Lee, Kian Leong ^a   Kitajima, Shojiro ^a   Yang, Henry ^a   Sun, Wendi ^a   Fukuhara, Noriko ^a   Zaiden, Norazean ^a   Chan, Shing Leng ^a   Tachibana, Makoto ^b   Shinkai, Yoichi ^b   Kato, Hiroyuki ^a   Poellinger, Lorenz ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b KYOTO UNIVERSITY   (Japan)

^c KAROLINSKA INSTITUTE   (Sweden)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; G9A PROTEIN; HISTONE H3; HISTONE METHYLTRANSFERASE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE HISTONE H3 LYSINE 9; JMJD1A PROTEIN; KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; LYSINE DERIVATIVE; MESSENGER RNA; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1,4 DIAZEPIN 1 YL) 6,7 DIMETHOXY 4 QUINAZOLINAMINE; NOTCH4 RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN KINASE ZAP 70; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; TISSUE FACTOR PATHWAY INHIBITOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; HISTOCOMPATIBILITY ANTIGEN; HISTONE DEMETHYLASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CELL DENSITY; CHROMATIN IMMUNOPRECIPITATION; CLONOGENESIS; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYONAL CARCINOMA; EMBRYONIC STEM CELL; ENZYME INHIBITION; EPIGENETICS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IC50; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; SEMINOMA; TESTIS; TRANSCRIPTION INITIATION; TUMOR GROWTH; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING; WILD TYPE; YOLK SAC TUMOR; ANIMAL; CELL HYPOXIA; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; KNOCKOUT MOUSE; METABOLISM; NEOPLASM; PATHOLOGY; STEM CELL; TESTIS TUMOR; TISSUE MICROARRAY;

ANIMALS; CELL HYPOXIA; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MALE; MICE; MICE, KNOCKOUT; NEOPLASMS, GERM CELL AND EMBRYONAL; STEM CELLS; TESTICULAR NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 84906956919     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00099-14     Document Type: Article

References (61)

1. Semenza GL. 2014. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu. Rev. Pathol. 9:47-71. http://dx.doi.org/10 .1146/annurev-pathol-012513-104720.
2. Pugh CW, Ratcliffe PJ. 2003. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9:677-684. http://dx.doi.org/10.1038 /nm0603-677.
3. Lendahl U, Lee K, Yang H, Poellinger L. 2009. Generating specificity and diversity in the transcriptional response to hypoxia. Nat. Rev. Genet. 10: 821-832. http://dx.doi.org/10.1038/nrg2665.
4. Ho¨ckel M, Vaupel P. 2001. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 93:266-276. http://dx.doi.org/10.1093/jnci/93.4.266.
5. Harris AL. 2002. Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2:38-47. http://dx.doi.org/10.1038/nrc704.
6. Chan DA, Giaccia AJ. 2007. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev. 26:333-339. http://dx.doi.org/10.1007/s10555 -007-9063-1.
7. Keith B, Johnson RS, Simon MC. 2011. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat. Rev. Cancer 12:9-22. http://dx.doi.org/10.1038/nrc3183.
8. Xia X, Lemieux ME, Li W, Carroll JS, Brown M, Liu XS, Kung AL. 2009. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc. Natl. Acad. Sci. U. S. A. 106:4260-4265. http://dx.doi.org/10.1073/pnas.0810067106.
9. Krieg A, Rankin E, Chan D, Razorenova O, Fernandez S, Giaccia A. 2010. Regulation of the histone demethylase JMJD1A by hypoxiainducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol. Cell. Biol. 30:344-353. http://dx.doi.org/10.1128/MCB .00444-09.
10. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, Zhang Y. 2006. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439:811-816. http://dx.doi.org/10 .1038/nature04433.
11. Yamane K, Toumazou C, Tsukada Y, Erdjument-Bromage H, Tempst P, Wong J, Zhang Y. 2006. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 125: 483-495. http://dx.doi.org/10.1016/j.cell.2006.03.027.
12. Okada Y, Scott G, Ray M, Mishina Y, Zhang Y. 2007. Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis. Nature 450:119-123. http://dx.doi.org/10.1038/nature06236.
13. Tateishi K, Okada Y, Kallin E, Zhang Y. 2009. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 458: 757-761. http://dx.doi.org/10.1038/nature07777.
14. Inagaki T, Tachibana M, Magoori K, Kudo H, Tanaka T, Okamura M, Naito M, Kodama T, Shinkai Y, Sakai J. 2009. Obesity and metabolic syndrome in histone demethylase JHDM2a-deficient mice. Genes Cells 14:991-1001. http://dx.doi.org/10.1111/j.1365-2443.2009.01326.x.
15. Loh Y, Zhang W, Chen X, George J, Ng H. 2007. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev. 21:2545-2557. http://dx.doi.org/10.1101/gad.1588207.
16. Niwa H. 2007. How is pluripotency determined and maintained? Development 134:635-646. http://dx.doi.org/10.1242/dev.02787.
17. Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, Fukuda M, Takeda N, Niida H, Kato H, Shinkai Y. 2002. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16:1779-1791. http://dx.doi.org/10.1101/gad.989402.
18. Tachibana M, Ueda J, Fukuda M, Takeda N, Ohta T, Iwanari H, Sakihama T, Kodama T, Hamakubo T, Shinkai Y. 2005. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev. 19:815-826. http://dx.doi.org/10.1101/gad.1284005.
19. Ueda J, Tachibana M, Ikura T, Shinkai Y. 2006. Zinc finger protein Wiz links G9a/GLP histone methyltransferases to the co-repressor molecule CtBP. J. Biol. Chem. 281:20120-20128. http://dx.doi.org/10.1074/jbc.M603087200.
20. Tachibana M, Matsumura Y, Fukuda M, Kimura H, Shinkai Y. 2008. G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J. 27:2681-2690. http://dx.doi.org/10 .1038/emboj.2008.192.
21. Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A, Ueda J, Deplus R, Fuks F, Shinkai Y, Cedar H, Bergman Y. 2008. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat. Struct. Mol. Biol. 15:1176-1183. http: //dx.doi.org/10.1038/nsmb.1476.
22. Chen H, Yan Y, Davidson T, Shinkai Y, Costa M. 2006. Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res. 66:9009-9016. http://dx.doi .org/10.1158/0008-5472.CAN-06-0101.
23. Lee S, Kim J, Kim W, Lee Y. 2009. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 28:184-194. http://dx.doi.org/10.1038/onc.2008.377.
24. Chen M, Hua K, Kao H, Chi C, Wei L, Johansson G, Shiah S, Chen P, Jeng Y, Cheng T, Lai T, Chang J, Jan Y, Chien M, Yang C, Huang M, Hsiao M, Kuo M. 2010. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res. 70:7830-7840. http://dx.doi.org/10.1158/0008 -5472.CAN-10-0833.
25. Cox WG, Singer VL. 1999. A high-resolution, fluorescence-based method for localization of endogenous alkaline phosphatase activity. J. Histochem. Cytochem. 47:1443-1456. http://dx.doi.org/10.1177/002215549904701110.
26. Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H, Pietras A, Vallon-Christersson J, Borg A, Gradin K, Poellinger L, Pahlman S. 2006. Recruitment of HIF-1alpha and HIF- 2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10: 413-423. http://dx.doi.org/10.1016/j.ccr.2006.08.026.
27. Yamagata K, Ueda J, Mizutani E, Saitou M, Wakayama T. 2010. Survival and death of epiblast cells during embryonic stem cell derivation revealed by long-term live-cell imaging with an Oct4 reporter system. Dev. Biol. 346:90-101. http://dx.doi.org/10.1016/j.ydbio.2010.07.021.
28. Chua SW, Vijayakumar P, Nissom PM, Yam CY, Wong VV, Yang H. 2006. A novel normalization method for effective removal of systematic variation in microarray data. Nucleic Acids Res. 34:e38. http://dx.doi.org /10.1093/nar/gkl024.
29. Uemura M, Yamamoto H, Takemasa I, Mimori K, Hemmi H, Mizushima T, Ikeda M, Sekimoto M, Matsuura N, Doki Y, Mori M. 2010. Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells. Clin. Cancer Res. 16:4636-4646. http://dx.doi.org/10.1158/1078-0432.CCR-10-0407.
30. Huang J, Dorsey J, Chuikov S, Perez-Burgos L, Zhang X, Jenuwein T, Reinberg D, Berger SL. 2010. G9a and Glp methylate lysine 373 in the tumor suppressor p53. J. Biol. Chem. 285:9636-9641. http://dx.doi.org /10.1074/jbc.M109.062588.
31. Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE, Bosl GJ, Chaganti RS. 2006. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res. 66:820-827. http://dx.doi.org/10.1158/0008-5472.CAN-05-2445.
32. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. 2004. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6:1-6. http://dx.doi.org/10.1016/S1476-5586(04)80047-2.
33. Kupershmidt I, Su QJ, Grewal A, Sundaresh S, Halperin I, Flynn J, Shekar M, Wang H, Park J, Cui W, Wall GD, Wisotzkey R, Alag S, Akhtari S, Ronaghi M. 2010. Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One 5(9):pii:e13066. http://dx.doi.org/10.1371/journal.pone.0013066.
34. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO, Thomson JA. 2003. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl. Acad. Sci. U. S. A. 100:13350-13355. http: //dx.doi.org/10.1073/pnas.2235735100.
35. Ezeh UI, Turek PJ, Reijo RA, Clark AT. 2005. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104:2255-2265. http://dx.doi .org/10.1002/cncr.21432.
36. Koumenis C, Naczki C, Koritzinsky M, Rastani S, Diehl A, Sonenberg N, Koromilas A, Wouters BG. 2002. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol. Cell. Biol. 22:7405-7416. http://dx.doi.org/10.1128/MCB.22.21.7405-7416.2002.
37. Koritzinsky M, Magagnin MG, van den Beucken T, Seigneuric R, Savelkouls K, Dostie J, Pyronnet S, Kaufman RJ, Weppler SA, Voncken JW, Lambin P, Koumenis C, Sonenberg N, Wouters BG. 2006. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J. 25:1114-1125. http://dx .doi.org/10.1038/sj.emboj.7600998.
38. Leong KG, Hu X, Li L, Noseda M, Larrivee B, Hull C, Hood L, Wong F, Karsan A. 2002. Activated Notch4 inhibits angiogenesis: role of beta 1-integrin activation. Mol. Cell. Biol. 22:2830-2841. http://dx.doi.org/10 .1128/MCB.22.8.2830-2841.2002.
39. Mousa SA, Mohamed S. 2004. Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor. Thromb. Haemost. 92:627-633. http://dx.doi .org/10.1267/THRO04090000.
40. Contois LW, Nugent DP, Caron JM, Cretu A, Tweedie E, Akalu A, Liebes L, Friesel R, Rosen C, Vary C, Brooks PC. 2012. Insulin-like growth factor binding protein-4 (IGFBP-4) differentially inhibits growth factor-induced angiogenesis. J. Biol. Chem. 287:1779-1789. http://dx.doi .org/10.1074/jbc.M111.267732.
41. Jones C, London N, Chen H, Park K, Sauvaget D, Stockton R, Wythe J, Suh W, Larrieu-Lahargue F, Mukouyama Y, Lindblom P, Seth P, Frias A, Nishiya N, Ginsberg M, Gerhardt H, Zhang K, Li D. 2008. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat. Med. 14:448-453. http://dx .doi.org/10.1038/nm1742.
42. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E, Grant DS. 1998. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ. Res. 83:187-195. http://dx.doi .org/10.1161/01.RES.83.2.187.
43. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE, Ren B. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39:311-318. http://dx.doi.org/10.1038/ng1966.
44. Gutierrez A, Kentsis A, Sanda T, Holmfeldt L, Chen SC, Zhang J, Protopopov A, Chin L, Dahlberg SE, Neuberg DS, Silverman LB, Winter SS, Hunger SP, Sallan SE, Zha S, Alt FW, Downing JR, Mullighan CG, Look AT. 2011. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. Blood 118:4169-4173. http://dx.doi.org/10.1182/blood-2010-11 -318873.
45. Kubicek S, O'Sullivan RJ, August EM, Hickey ER, Zhang Q, Teodoro ML, Rea S, Mechtler K, Kowalski JA, Homon CA, Kelly TA, Jenuwein T. 2007. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol. Cell 25:473-481. http://dx.doi.org/10 .1016/j.molcel.2007.01.017.
46. Chang Y, Zhang X, Horton JR, Upadhyay AK, Spannhoff A, Liu J, Snyder JP, Bedford MT, Cheng X. 2009. Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294. Nat. Struct. Mol. Biol. 16:312-317. http://dx.doi.org/10.1038/nsmb.1560.
47. Kuroki S, Matoba S, Akiyoshi M, Matsumura Y, Miyachi H, Mise N, Abe K, Ogura A, Wilhelm D, Koopman P, Nozaki M, Kanai Y, Shinkai Y, Tachibana M. 2013. Epigenetic regulation of mouse sex determination by the histone demethylase Jmjd1a. Science 341:1106-1109. http://dx.doi .org/10.1126/science.1239864.
48. Herzog M, Josseaux E, Dedeurwaerder S, Calonne E, Volkmar M, Fuks F. 2012. The histone demethylase Kdm3a is essential to progression through differentiation. Nucleic Acids Res. 40:7219-7232. http://dx.doi .org/10.1093/nar/gks399.
49. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW. 2003. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 63:2244-2250.
50. Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LH, Pauchnik M, Chow CW, Robb L. 2005. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 104:2092-2098. http://dx .doi.org/10.1002/cncr.21435.
51. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. 2008. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40: 499-507. http://dx.doi.org/10.1038/ng.127.
52. Cantz T, Key G, Bleidissel M, Gentile L, Han DW, Brenne A, Scholer HR. 2008. Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 26:692-697. http://dx.doi.org/10.1634/stemcells.2007-0657.
53. Mimura I, Nangaku M, Kanki Y, Tsutsumi S, Inoue T, Kohro T, Yamamoto S, Fujita T, Shimamura T, Suehiro J, Taguchi A, Kobayashi M, Tanimura K, Inagaki T, Tanaka T, Hamakubo T, Sakai J, Aburatani H, Kodama T, Wada Y. 2012. Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A. Mol. Cell. Biol. 32:3018-3032. http://dx.doi.org/10.1128/MCB.06643-11.
54. Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP. 2009. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat. Genet. 41:246-250. http://dx.doi.org/10 .1038/ng.297.
55. Gyory I, Wu J, Fejer G, Seto E, Wright KL. 2004. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat. Immunol. 5:299-308. http://dx.doi.org/10.1038/ni1046.
56. Banck MS, Li S, Nishio H, Wang C, Beutler AS, Walsh MJ. 2009. The ZNF217 oncogene is a candidate organizer of repressive histone modifiers. Epigenetics 4:100-106. http://dx.doi.org/10.4161/epi.4.2.7953.
57. Beyer S, Kristensen M, Jensen K, Johansen J, Staller P. 2008. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxiainducible factor HIF. J. Biol. Chem. 283:36542-36552. http://dx.doi.org /10.1074/jbc.M804578200.
58. Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW, Moon EJ, Kim HS, Lee SK, Chung HY, Kim CW, Kim KW. 2001. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7:437-443. http://dx.doi.org/10.1038/86507.
59. Gorospe M, Tominaga K, Wu X, Fahling M, Ivan M. 2011. Posttranscriptional control of the hypoxic response by RNA-binding proteins and microRNAs. Front. Mol. Neurosci. 4:7. http://dx.doi.org/10.3389 /fnmol.2011.00007.
60. Cao P, Deng Z, Wan M, Huang W, Cramer SD, Xu J, Lei M, Sui G. 2010. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol. Cancer 9:108. http://dx.doi.org/10.1186/1476-4598-9-108.
61. Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, Yamauchi J, Matsuno S, Shibahara S, Abraham NG. 2003. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 6:15-24. http://dx.doi.org/10.1023/A:1025803600840.